Wolfgang Otto - Concepedia

Author

Wolfgang Otto

Also Known As

Arndt Hartmann, Otto, W., Otto, Wolfgang, W OTTO, W Otto, W. K. Otto, W. Otto, Wolfgang Otto, for DNA and protein binding) as well as using novel sources of information

317

Publications

6.7K

Citations

H-Index

114

Concepts

All Affiliations

University of Regensburg Friedrich-Alexander-Universität Erlangen-Nürnberg Heidelberg University Universitätsklinikum Erlangen University Hospital Heidelberg

About

Wolfgang Otto is an author at University of Regensburg specializing in medicine, urology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	31	51	2.8K
2	Natural Sciences	8	8	236
3	Engineering	2	2	111
4	Health Sciences	2	2	124
5	Public Health	2	2	138

Wolfgang Otto

118

Publications

Citations

H-Index

Page 1

	Year	Citations
Gut microbiota disturbance during antibiotic therapy: a multi-omic approach Ana Elena Pérez‐Cobas, María José Gosalbes, Anette Friedrichs, Gut	2012	603
Gene expression studies in kiwifruit and gene over-expression in Arabidopsis indicates that GDP-L-galactose guanyltransferase is a major control point of vitamin C biosynthesis Sean Bulley, Maysoon Rassam, Dana Hoser, Journal of Experimental Botany	2009	279
Higher plasma levels of lysophosphatidylcholine 18:0 are related to a lower risk of common cancers in a prospective metabolomics study Tilman Kühn, Anna Floegel, Disorn Sookthai, BMC Medicine	2016	229
The Tumor Immune Microenvironment Drives a Prognostic Relevance That Correlates with Bladder Cancer Subtypes Carolin Pfannstiel, Pamela L. Strissel, Katherine B. Chiappinelli, Cancer Immunology Research ImmunologyBiological MicroenvironmentsPathologyImmunoeditingImmunotherapy	2019	224
Early Versus Deferred Cystectomy for Initial High-Risk pT1G3 Urothelial Carcinoma of the Bladder: Do Risk Factors Define Feasibility of Bladder-Sparing Approach? Stefan Denzinger, Hans‐Martin Fritsche, Wolfgang Otto, European Urology Urological ResearchUrologySurgical OncologyGenitourinary CancerBladder-sparing Approach	2007	210
Characteristics and Outcomes of Patients with Clinical T1 Grade 3 Urothelial Carcinoma Treated with Radical Cystectomy: Results from an International Cohort Hans‐Martin Fritsche, Maximilian Burger, Robert S. Svatek, European Urology Radical CystectomySurgical OncologyUrologyUrologic Cancer EpidemiologyGenitourinary Cancer	2009	198
Gender differences in radical nephroureterectomy for upper tract urothelial carcinoma Shahrokh F. Shariat, Ricardo L. Favaretto, Amit Gupta, World Journal of Urology Surgical OncologyUrologyGenitourinary CancerMedicineGender Differences	2010	187
Combination of CK20 and Ki-67 Immunostaining Analysis Predicts Recurrence, Progression, and Cancer-Specific Survival in pT1 Urothelial Bladder Cancer Simone Bertz, Wolfgang Otto, Stefan Denzinger, European Urology UrologyUrologic Cancer EpidemiologyGenitourinary CancerMedicinePathology	2012	103
miR‐124‐regulated RhoG reduces neuronal process complexity via ELMO/Dock180/Rac1 and Cdc42 signalling Kristin Franke, Wolfgang Otto, Sascha Johannes, The EMBO Journal	2012	100
Performance of the Food and Drug Administration/EMA-approved programmed cell death ligand-1 assays in urothelial carcinoma with emphasis on therapy stratification for first-line use of atezolizumab and pembrolizumab Markus Eckstein, Philipp Erben, Maximilian C. Kriegmair, European Journal of Cancer UrologyGenitourinary CancerTherapy StratificationUrothelial CarcinomaMedicine	2018	100

Page 1